ID   H33_RAT                 Reviewed;         136 AA.
AC   P84245; P06351; P33155; Q5RJM5; Q9V3W4;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   02-OCT-2024, entry version 165.
DE   RecName: Full=Histone H3.3;
GN   Name=H3-3b {ECO:0000250|UniProtKB:P84243};
GN   Synonyms=H3.3b, H3f3b {ECO:0000312|RGD:621095};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley; TISSUE=Embryonic brain;
RX   PubMed=7877725; DOI=10.1007/bf00969002;
RA   Castiglia D., Cestelli A., Scaturro M., Nastasi T., Di Liegro I.;
RT   "H1(0) and H3.3B mRNA levels in developing rat brain.";
RL   Neurochem. Res. 19:1531-1537(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Pituitary, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION AT SER-11 AND THR-12.
RX   PubMed=12560483; DOI=10.1093/nar/gkg176;
RA   Preuss U., Landsberg G., Scheidtmann K.H.;
RT   "Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by
RT   Dlk/ZIP kinase.";
RL   Nucleic Acids Res. 31:878-885(2003).
RN   [4]
RP   UBIQUITINATION.
RX   PubMed=9582357; DOI=10.1074/jbc.273.21.13165;
RA   Chen H.Y., Sun J.-M., Zhang Y., Davie J.R., Meistrich M.L.;
RT   "Ubiquitination of histone H3 in elongating spermatids of rat testes.";
RL   J. Biol. Chem. 273:13165-13169(1998).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND ACETYLATION AT LYS-37.
RX   PubMed=19343714; DOI=10.1002/pmic.200800558;
RA   Pramod K.S., Bharat K., Sanjay G.;
RT   "Mass spectrometry-compatible silver staining of histones resolved on
RT   acetic acid-urea-Triton PAGE.";
RL   Proteomics 9:2589-2592(2009).
RN   [6]
RP   DOPAMINYLATION AT GLN-6, AND MUTAGENESIS OF GLN-6.
RX   PubMed=32273471; DOI=10.1126/science.aaw8806;
RA   Lepack A.E., Werner C.T., Stewart A.F., Fulton S.L., Zhong P.,
RA   Farrelly L.A., Smith A.C.W., Ramakrishnan A., Lyu Y., Bastle R.M.,
RA   Martin J.A., Mitra S., O'Connor R.M., Wang Z.J., Molina H., Turecki G.,
RA   Shen L., Yan Z., Calipari E.S., Dietz D.M., Kenny P.J., Maze I.;
RT   "Dopaminylation of histone H3 in ventral tegmental area regulates cocaine
RT   seeking.";
RL   Science 368:197-201(2020).
CC   -!- FUNCTION: Variant histone H3 which replaces conventional H3 in a wide
CC       range of nucleosomes in active genes. Constitutes the predominant form
CC       of histone H3 in non-dividing cells and is incorporated into chromatin
CC       independently of DNA synthesis. Deposited at sites of nucleosomal
CC       displacement throughout transcribed genes, suggesting that it
CC       represents an epigenetic imprint of transcriptionally active chromatin.
CC       Nucleosomes wrap and compact DNA into chromatin, limiting DNA
CC       accessibility to the cellular machineries which require DNA as a
CC       template. Histones thereby play a central role in transcription
CC       regulation, DNA repair, DNA replication and chromosomal stability. DNA
CC       accessibility is regulated via a complex set of post-translational
CC       modifications of histones, also called histone code, and nucleosome
CC       remodeling. {ECO:0000250|UniProtKB:P84243}.
CC   -!- SUBUNIT: The nucleosome is a histone octamer containing two molecules
CC       each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and
CC       two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of
CC       DNA. Interacts with HIRA, a chaperone required for its incorporation
CC       into nucleosomes. Interacts with ZMYND11; when trimethylated at 'Lys-
CC       36' (H3.3K36me3). Found in a co-chaperone complex with DNJC9, MCM2 and
CC       histone H3.3-H4 dimers (By similarity). Within the complex, interacts
CC       with DNJC9 (via C-terminus); the interaction is direct (By similarity).
CC       Interacts with ASF1A, MCM2, NASP and SPT2 (By similarity). Interacts
CC       with DAXX; the interaction is direct (By similarity). Interacts with
CC       NASP; NASP is a histone chaperone that stabilizes and maintains a
CC       soluble pool of Histone H3-H4 dimers (By similarity).
CC       {ECO:0000250|UniProtKB:P84243}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome {ECO:0000250}.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout the cell cycle independently
CC       of DNA synthesis. Levels increase from embryonic day 18 to postnatal
CC       day 10. {ECO:0000269|PubMed:7877725}.
CC   -!- DOMAIN: Specific interaction of trimethylated form at 'Lys-36'
CC       (H3.3K36me3) with ZMYND11 is mediated by the encapsulation of Ser-32
CC       residue with a composite pocket formed by the tandem bromo-PWWP domains
CC       (By similarity). Interacts with ZMYND11; when trimethylated at 'Lys-36'
CC       (H3.3K36me3). {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Acetylation is generally linked to gene activation. Acetylation on
CC       Lys-10 (H3K9ac) impairs methylation at Arg-9 (H3R8me2s). Acetylation on
CC       Lys-19 (H3K18ac) and Lys-24 (H3K24ac) favors methylation at Arg-18
CC       (H3R17me). Acetylation at Lys-123 (H3K122ac) by EP300/p300 plays a
CC       central role in chromatin structure: localizes at the surface of the
CC       histone octamer and stimulates transcription, possibly by promoting
CC       nucleosome instability. {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Citrullination at Arg-9 (H3R8ci) and/or Arg-18 (H3R17ci) by PADI4
CC       impairs methylation and represses transcription.
CC       {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Asymmetric dimethylation at Arg-18 (H3R17me2a) by CARM1 is linked
CC       to gene activation. Symmetric dimethylation at Arg-9 (H3R8me2s) by
CC       PRMT5 is linked to gene repression. Asymmetric dimethylation at Arg-3
CC       (H3R2me2a) by PRMT6 is linked to gene repression and is mutually
CC       exclusive with H3 Lys-5 methylation (H3K4me2 and H3K4me3). H3R2me2a is
CC       present at the 3' of genes regardless of their transcription state and
CC       is enriched on inactive promoters, while it is absent on active
CC       promoters. {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Specifically enriched in modifications associated with active
CC       chromatin such as methylation at Lys-5 (H3K4me), Lys-37 and Lys-80.
CC       Methylation at Lys-5 (H3K4me) facilitates subsequent acetylation of H3
CC       and H4. Methylation at Lys-80 (H3K79me) is associated with DNA double-
CC       strand break (DSB) responses and is a specific target for TP53BP1.
CC       Methylation at Lys-10 (H3K9me) and Lys-28 (H3K27me), which are linked
CC       to gene repression, are underrepresented. Methylation at Lys-10
CC       (H3K9me) is a specific target for HP1 proteins (CBX1, CBX3 and CBX5)
CC       and prevents subsequent phosphorylation at Ser-11 (H3S10ph) and
CC       acetylation of H3 and H4. Methylation at Lys-5 (H3K4me) and Lys-80
CC       (H3K79me) require preliminary monoubiquitination of H2B at 'Lys-120'.
CC       Methylation at Lys-10 (H3K9me) and Lys-28 (H3K27me) are enriched in
CC       inactive X chromosome chromatin. Monomethylation at Lys-57 (H3K56me1)
CC       by EHMT2/G9A in G1 phase promotes interaction with PCNA and is required
CC       for DNA replication. {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Phosphorylated at Thr-4 (H3T3ph) by VRK1 (By similarity).
CC       Phosphorylated at Thr-4 (H3T3ph) by HASPIN during prophase and
CC       dephosphorylated during anaphase. Phosphorylation at Ser-11 (H3S10ph)
CC       by AURKB is crucial for chromosome condensation and cell-cycle
CC       progression during mitosis and meiosis. In addition phosphorylation at
CC       Ser-11 (H3S10ph) by RPS6KA4 and RPS6KA5 is important during interphase
CC       because it enables the transcription of genes following external
CC       stimulation, like mitogens, stress, growth factors or UV irradiation
CC       and result in the activation of genes, such as c-fos and c-jun.
CC       Phosphorylation at Ser-11 (H3S10ph), which is linked to gene
CC       activation, prevents methylation at Lys-10 (H3K9me) but facilitates
CC       acetylation of H3 and H4. Phosphorylation at Ser-11 (H3S10ph) by AURKB
CC       mediates the dissociation of HP1 proteins (CBX1, CBX3 and CBX5) from
CC       heterochromatin. Phosphorylation at Ser-11 (H3S10ph) is also an
CC       essential regulatory mechanism for neoplastic cell transformation.
CC       Phosphorylated at Ser-29 (H3S28ph) by MAP3K20 isoform 1, RPS6KA5 or
CC       AURKB during mitosis or upon ultraviolet B irradiation. Phosphorylation
CC       at Thr-7 (H3T6ph) by PRKCB is a specific tag for epigenetic
CC       transcriptional activation that prevents demethylation of Lys-5
CC       (H3K4me) by LSD1/KDM1A. At centromeres, specifically phosphorylated at
CC       Thr-12 (H3T11ph) from prophase to early anaphase, by DAPK3 and PKN1.
CC       Phosphorylation at Thr-12 (H3T11ph) by PKN1 or isoform M2 of PKM (PKM2)
CC       is a specific tag for epigenetic transcriptional activation that
CC       promotes demethylation of Lys-10 (H3K9me) by KDM4C/JMJD2C.
CC       Phosphorylation at Tyr-42 (H3Y41ph) by JAK2 promotes exclusion of CBX5
CC       (HP1 alpha) from chromatin. Phosphorylation on Ser-32 (H3S31ph) is
CC       specific to regions bordering centromeres in metaphase chromosomes.
CC       {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Ubiquitinated. Monoubiquitinated by RAG1 in lymphoid cells,
CC       monoubiquitination is required for V(D)J recombination (By similarity).
CC       {ECO:0000250, ECO:0000269|PubMed:9582357}.
CC   -!- PTM: Lysine deamination at Lys-5 (H3K4all) to form allysine is mediated
CC       by LOXL2. Allysine formation by LOXL2 only takes place on H3K4me3 and
CC       results in gene repression. {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Crotonylation (Kcr) is specifically present in male germ cells and
CC       marks testis-specific genes in post-meiotic cells, including X-linked
CC       genes that escape sex chromosome inactivation in haploid cells.
CC       Crotonylation marks active promoters and enhancers and confers
CC       resistance to transcriptional repressors. It is also associated with
CC       post-meiotically activated genes on autosomes.
CC       {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Butyrylation of histones marks active promoters and competes with
CC       histone acetylation. It is present during late spermatogenesis.
CC       {ECO:0000250|UniProtKB:P68433}.
CC   -!- PTM: Succinylation at Lys-80 (H3K79succ) by KAT2A takes place with a
CC       maximum frequency around the transcription start sites of genes. It
CC       gives a specific tag for epigenetic transcription activation.
CC       Desuccinylation at Lys-123 (H3K122succ) by SIRT7 in response to DNA
CC       damage promotes chromatin condensation and double-strand breaks (DSBs)
CC       repair. {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Serine ADP-ribosylation by PARP1 or PARP2 constitutes the primary
CC       form of ADP-ribosylation of proteins in response to DNA damage. Serine
CC       ADP-ribosylation at Ser-11 (H3S10ADPr) promotes recruitment of CHD1L.
CC       H3S10ADPr is mutually exclusive with phosphorylation at Ser-11
CC       (H3S10ph) and impairs acetylation at Lys-10 (H3K9ac).
CC       {ECO:0000250|UniProtKB:P68431}.
CC   -!- PTM: Serotonylated by TGM2 at Gln-6 (H3Q5ser) during serotonergic
CC       neuron differentiation (By similarity). H3Q5ser is associated with
CC       trimethylation of Lys-5 (H3K4me3) and enhances general transcription
CC       factor IID (TFIID) complex-binding to H3K4me3, thereby facilitating
CC       transcription (By similarity). {ECO:0000250|UniProtKB:P84243}.
CC   -!- PTM: Dopaminylated by TGM2 at Gln-6 (H3Q5dop) in ventral tegmental area
CC       (VTA) neurons (PubMed:32273471). H3Q5dop mediates neurotransmission-
CC       independent role of nuclear dopamine by regulating relapse-related
CC       transcriptional plasticity in the reward system (PubMed:32273471).
CC       {ECO:0000269|PubMed:32273471}.
CC   -!- PTM: Lactylated in macrophages by EP300/P300 by using lactoyl-CoA
CC       directly derived from endogenous or exogenous lactate, leading to
CC       stimulates gene transcription. {ECO:0000250|UniProtKB:P84243}.
CC   -!- SIMILARITY: Belongs to the histone H3 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X73683; CAA52035.1; -; mRNA.
DR   EMBL; BC063159; AAH63159.1; -; mRNA.
DR   EMBL; BC078759; AAH78759.1; -; mRNA.
DR   EMBL; BC086580; AAH86580.1; -; mRNA.
DR   EMBL; BC087725; AAH87725.1; -; mRNA.
DR   PIR; S34185; S34185.
DR   RefSeq; NP_446437.1; NM_053985.2.
DR   RefSeq; XP_002728089.1; XM_002728043.3.
DR   RefSeq; XP_003752732.1; XM_003752684.4.
DR   AlphaFoldDB; P84245; -.
DR   SMR; P84245; -.
DR   BioGRID; 250653; 4.
DR   IntAct; P84245; 1.
DR   MINT; P84245; -.
DR   STRING; 10116.ENSRNOP00000004329; -.
DR   iPTMnet; P84245; -.
DR   SwissPalm; P84245; -.
DR   jPOST; P84245; -.
DR   PaxDb; 10116-ENSRNOP00000004329; -.
DR   Ensembl; ENSRNOT00000004329.8; ENSRNOP00000004329.4; ENSRNOG00000003220.8.
DR   Ensembl; ENSRNOT00000050223.4; ENSRNOP00000040434.3; ENSRNOG00000006532.6.
DR   Ensembl; ENSRNOT00055021290; ENSRNOP00055017225; ENSRNOG00055012486.
DR   Ensembl; ENSRNOT00055022653; ENSRNOP00055018408; ENSRNOG00055013215.
DR   Ensembl; ENSRNOT00055056311; ENSRNOP00055046453; ENSRNOG00055032581.
DR   Ensembl; ENSRNOT00060011575; ENSRNOP00060008694; ENSRNOG00060007048.
DR   Ensembl; ENSRNOT00060044229; ENSRNOP00060036675; ENSRNOG00060025541.
DR   Ensembl; ENSRNOT00060054108; ENSRNOP00060044883; ENSRNOG00060031181.
DR   Ensembl; ENSRNOT00065028436; ENSRNOP00065022494; ENSRNOG00065017038.
DR   Ensembl; ENSRNOT00065035867; ENSRNOP00065028926; ENSRNOG00065021089.
DR   GeneID; 117056; -.
DR   KEGG; rno:117056; -.
DR   AGR; RGD:2319910; -.
DR   AGR; RGD:621095; -.
DR   CTD; 15081; -.
DR   RGD; 621095; H3f3b.
DR   eggNOG; KOG1745; Eukaryota.
DR   GeneTree; ENSGT01110000267215; -.
DR   HOGENOM; CLU_078295_4_0_1; -.
DR   InParanoid; P84245; -.
DR   OMA; KHKMART; -.
DR   OrthoDB; 3867165at2759; -.
DR   PhylomeDB; P84245; -.
DR   TreeFam; TF314241; -.
DR   Reactome; R-RNO-212300; PRC2 methylates histones and DNA.
DR   Reactome; R-RNO-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-RNO-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-RNO-427359; SIRT1 negatively regulates rRNA expression.
DR   Reactome; R-RNO-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-RNO-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-RNO-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-RNO-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-RNO-68616; Assembly of the ORC complex at the origin of replication.
DR   Reactome; R-RNO-73728; RNA Polymerase I Promoter Opening.
DR   Reactome; R-RNO-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-RNO-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-RNO-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-RNO-983231; Factors involved in megakaryocyte development and platelet production.
DR   Reactome; R-RNO-9843940; Regulation of endogenous retroelements by KRAB-ZFP proteins.
DR   Reactome; R-RNO-9843970; Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex.
DR   PRO; PR:P84245; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000003220; Expressed in thymus and 18 other cell types or tissues.
DR   ExpressionAtlas; P84245; baseline and differential.
DR   GO; GO:0000781; C:chromosome, telomeric region; ISO:RGD.
DR   GO; GO:0000786; C:nucleosome; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0031492; F:nucleosomal DNA binding; ISO:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0030527; F:structural constituent of chromatin; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0007566; P:embryo implantation; ISO:RGD.
DR   GO; GO:0008584; P:male gonad development; ISO:RGD.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:0042692; P:muscle cell differentiation; ISO:RGD.
DR   GO; GO:1902340; P:negative regulation of chromosome condensation; ISO:RGD.
DR   GO; GO:0006334; P:nucleosome assembly; ISO:RGD.
DR   GO; GO:0006997; P:nucleus organization; ISO:RGD.
DR   GO; GO:0048477; P:oogenesis; ISO:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; ISO:RGD.
DR   GO; GO:0031508; P:pericentric heterochromatin formation; ISO:RGD.
DR   GO; GO:0030307; P:positive regulation of cell growth; ISO:RGD.
DR   GO; GO:0090230; P:regulation of centromere complex assembly; ISO:RGD.
DR   GO; GO:0009725; P:response to hormone; IEP:RGD.
DR   GO; GO:0007338; P:single fertilization; ISO:RGD.
DR   GO; GO:0007286; P:spermatid development; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.
DR   GO; GO:0031509; P:subtelomeric heterochromatin formation; ISO:RGD.
DR   Gene3D; 1.10.20.10; Histone, subunit A; 1.
DR   InterPro; IPR009072; Histone-fold.
DR   InterPro; IPR007125; Histone_H2A/H2B/H3.
DR   InterPro; IPR000164; Histone_H3/CENP-A.
DR   PANTHER; PTHR11426; HISTONE H3; 1.
DR   PANTHER; PTHR11426:SF277; HISTONE H3.3; 1.
DR   Pfam; PF00125; Histone; 1.
DR   PRINTS; PR00622; HISTONEH3.
DR   SMART; SM00428; H3; 1.
DR   SUPFAM; SSF47113; Histone-fold; 1.
DR   PROSITE; PS00322; HISTONE_H3_1; 1.
DR   PROSITE; PS00959; HISTONE_H3_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ADP-ribosylation; Chromosome; Citrullination; DNA-binding;
KW   Hydroxylation; Lipoprotein; Methylation; Nucleosome core; Nucleus;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   CHAIN           2..136
FT                   /note="Histone H3.3"
FT                   /id="PRO_0000221254"
FT   REGION          1..43
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            32
FT                   /note="Interaction with ZMYND11"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         3
FT                   /note="Asymmetric dimethylarginine; by PRMT6; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         3
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         4
FT                   /note="Phosphothreonine; by HASPIN and VRK1"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         5
FT                   /note="Allysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         5
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         5
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         5
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         5
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         5
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         5
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         6
FT                   /note="5-glutamyl dopamine; alternate"
FT                   /evidence="ECO:0000269|PubMed:32273471"
FT   MOD_RES         6
FT                   /note="5-glutamyl serotonin; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         7
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         9
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         9
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84244"
FT   MOD_RES         10
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         10
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         10
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         10
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         10
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         10
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         10
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         10
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         11
FT                   /note="ADP-ribosylserine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         11
FT                   /note="Phosphoserine; alternate; by AURKB, AURKC, RPS6KA3,
FT                   RPS6KA4 and RPS6KA5"
FT                   /evidence="ECO:0000269|PubMed:12560483"
FT   MOD_RES         12
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:12560483"
FT   MOD_RES         15
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         15
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         15
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         15
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         15
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84244"
FT   MOD_RES         15
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         18
FT                   /note="Asymmetric dimethylarginine; by CARM1; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         18
FT                   /note="Citrulline; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         19
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         19
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         19
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         19
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         19
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         19
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         19
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         19
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         24
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         24
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         24
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         24
FT                   /note="N6-butyryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         24
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         24
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         24
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         24
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         27
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         28
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         28
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         28
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         28
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         28
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         28
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         28
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         28
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         29
FT                   /note="ADP-ribosylserine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         29
FT                   /note="Phosphoserine; alternate; by AURKB, AURKC and
FT                   RPS6KA5"
FT                   /evidence="ECO:0000250|UniProtKB:Q5E9F8"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         37
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         37
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         37
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         37
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:19343714"
FT   MOD_RES         37
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         38
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         42
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         57
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         57
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         57
FT                   /note="N6-(beta-hydroxybutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68433"
FT   MOD_RES         57
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         57
FT                   /note="N6-crotonyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         57
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         57
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84244"
FT   MOD_RES         57
FT                   /note="N6-methyllysine; by EHMT2; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         57
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         65
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         65
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         80
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84244"
FT   MOD_RES         80
FT                   /note="N6,N6-dimethyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         80
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         80
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         80
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         80
FT                   /note="N6-lactoyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         80
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         80
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         81
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         87
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         108
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q71DI3"
FT   MOD_RES         116
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         116
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         123
FT                   /note="N6-(2-hydroxyisobutyryl)lysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P68431"
FT   MOD_RES         123
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         123
FT                   /note="N6-glutaryllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         123
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MOD_RES         123
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   LIPID           19
FT                   /note="N6-decanoyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P84243"
FT   MUTAGEN         6
FT                   /note="Q->A: Abolished dopaminylation by TGM2. Impaired
FT                   regulation of relapse-related transcriptional plasticity in
FT                   the reward system."
FT                   /evidence="ECO:0000269|PubMed:32273471"
SQ   SEQUENCE   136 AA;  15328 MW;  5158ED279E6F9E1C CRC64;
     MARTKQTARK STGGKAPRKQ LATKAARKSA PSTGGVKKPH RYRPGTVALR EIRRYQKSTE
     LLIRKLPFQR LVREIAQDFK TDLRFQSAAI GALQEASEAY LVGLFEDTNL CAIHAKRVTI
     MPKDIQLARR IRGERA
//
